$8.21
-0.07 (-0.85%)
Open$8.13
Previous Close$8.28
Day High$8.39
Day Low$7.54
52W High$15.74
52W Low$1.55
Volume—
Avg Volume445.8K
Market Cap38.08M
P/E Ratio—
EPS$-18.75
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+329.4% upside
Current
$8.21
$8.21
Target
$35.25
$35.25
$27.20
$35.25 avg
$53.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.98M | 7.00M | 7.72M |
| Net Income | -1,326,181 | -1,545,557 | -1,571,652 |
| Profit Margin | -19.0% | -22.1% | -20.4% |
| EBITDA | -1,878,590 | -1,945,549 | -2,406,257 |
| Free Cash Flow | -1,092,947 | -1,597,568 | -1,077,092 |
| Rev Growth | +10.9% | +1.3% | +2.5% |
| Debt/Equity | 0.21 | 0.18 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |